Temperature Management in Anesthetized Patients: Hypothermia and Hyperthermia

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Anesthetic agents disrupt normal thermoregulation by lowering the hypothalamic set point, impairing thermal signaling, and suppressing efferent responses, leading to a widened interthreshold range and poikilothermia.
• Hypothermia during anesthesia progresses through three phases: rapid redistribution within minutes of induction, a slower linear decline due to environmental heat loss for 1-3 hours, and a plateau when warming efforts match heat loss.
• Core temperature monitoring is critical, with the esophagus, nasopharynx, rectum, and tympanic membrane offering the most reliable readings, though each has distinct lag times and artifact risks.
• Active warming modalities, including forced-air warming, circulating water blankets, and conductive warmers, are essential for preventing and managing hypothermia, with forced-air systems being the most effective in small animal practice.
• Hyperthermia under anesthesia is typically iatrogenic due to excessive warming or can be triggered by infection, malignant hyperthermia, or certain drugs, requiring prompt identification of the cause and appropriate cooling interventions.
• Even mild temperature deviations (≥1°C) can significantly impact neurologic outcome in ischemic injury models and alter metabolic rate, cardiac function, coagulation, and drug metabolism, underscoring the importance of strict perioperative temperature control.

Perioperative temperature disturbances are among the most common and clinically consequential complications of veterinary anesthesia. This article provides a framework for preventing, detecting, and managing hypothermia and hyperthermia in anesthetized dogs, cats, and other veterinary species. It is written for practicing veterinarians and veterinary anesthetists who need practical monitoring strategies, warming techniques, and decision criteria applicable across species.

The article addresses three clinical questions: how body temperature changes during anesthesia and why those changes matter, which monitoring sites and devices provide reliable temperature data, and what interventions are appropriate for each phase of the anesthetic period. Species differences, equipment limitations, and areas of genuine uncertainty are highlighted throughout. Specific drug protocols and dose calculations are excluded, readers should consult current formularies for drug-specific guidance.

At a Glance

Physiology of Temperature Regulation Under Anesthesia

Normal Thermoregulatory Control

Mammals and birds maintain core temperature within a narrow range through coordinated autonomic and behavioral responses. The preoptic area of the anterior hypothalamus integrates thermal input from peripheral thermoreceptors in the skin and deep thermoreceptors in the viscera, spinal cord, and brain. When core temperature deviates from the set point, the hypothalamus triggers vasoconstriction, piloerection, shivering, nonshivering thermogenesis, and behavioral adjustments to restore thermal balance.

General anesthesia disrupts this system at multiple levels. Anesthetic agents lower the hypothalamic set point, impair afferent thermal signaling, and suppress efferent thermoregulatory responses. The result is a widening of the interthreshold range, the interval between the thresholds for sweating and vasoconstriction, from approximately 0.2°C in conscious individuals to 2 to 4°C under anesthesia. Within this expanded range, the patient is poikilothermic and passively assumes the temperature of the environment.

The Three Phases of Anesthetic Hypothermia

Anesthesia-related hypothermia follows a predictable temporal pattern. The first phase, redistribution hypothermia, begins within minutes of induction. Anesthetic-induced vasodilation allows warm blood from the core to mix with cooler peripheral compartments, producing a rapid drop in core temperature of 1.0 to 1.5°C even when the patient is actively warmed. This phase is difficult to prevent entirely because it represents internal heat movement instead of heat loss to the environment.

The second phase is a slower, linear decline in core temperature lasting 1 to 3 hours. This phase reflects net heat loss to the environment through radiation, convection, conduction, and evaporation from surgical incisions and exposed body surfaces. The rate of decline depends on ambient temperature, patient size, surface area to mass ratio, and the extent of surgical exposure. Small patients with high surface area to mass ratios cool faster than large patients.

The third phase is a plateau during which core temperature stabilizes. This occurs when the patient's own thermoregulatory responses, particularly vasoconstriction, partially return as anesthetic depth lightens or when active warming matches heat loss. The plateau may not occur until core temperature has fallen several degrees below normal.

Metabolic and Cardiovascular Consequences

Hypothermia reduces metabolic rate by approximately 6 to 9% per degree Celsius drop in core temperature. This metabolic depression decreases oxygen consumption and carbon dioxide production, which can falsely reassure the anesthetist when interpreting capnography and metabolic monitoring. The AAHA anesthesia and monitoring guidelines for dogs and cats emphasize that temperature must be interpreted alongside other physiologic parameters instead of in isolation.

Cardiovascular effects include bradycardia, increased systemic vascular resistance, and reduced cardiac output. Hypothermia prolongs the action potential duration and alters myocardial conduction, predisposing patients to arrhythmias. Coagulation is impaired through reduced platelet function and enzyme activity in the clotting cascade. Hepatic and renal blood flow decrease, slowing drug metabolism and delaying recovery from anesthesia.

The neurologic consequences of even mild temperature changes are significant. In a canine model of complete cerebral ischemia, temperature elevations of just 1 to 2°C during the peri-ischemic period worsened functional neurologic outcome and increased histopathologic injury compared with normothermic controls. This finding, reported in the institutional publication Temperature changes of ≥1°C alter functional neurologic outcome and histopathology in a canine model of complete cerebral ischemia, underscores the importance of strict temperature control in neurologically compromised patients.

Brain-Body Temperature Gradients

Core temperature measured at standard sites does not always reflect brain temperature. Experimental work in rats anesthetized with sodium pentobarbital demonstrated that brain temperature falls more than body core temperature during anesthesia, with a brain-body differential of 0.3 to 0.4°C in unwarmed animals. External body warming reduced but did not eliminate this gradient, and it actually increased the brain-body temperature difference. These observations, published in Brain and body temperature homeostasis during sodium pentobarbital anesthesia with and without body warming in rats, suggest that brain temperature is influenced by local metabolic heat production as well as by arterial blood temperature. The clinical implication is that peripheral warming alone may not fully protect cerebral temperature homeostasis.

Mechanisms of Hyperthermia Under Anesthesia

Passive Hyperthermia and Excessive Warming

Hyperthermia during anesthesia occurs when heat gain exceeds heat loss. The most common cause is iatrogenic: excessive active warming combined with impaired thermoregulatory vasodilation and sweating. Forced-air warmers set to high output, circulating water blankets at excessive temperatures, and warmed irrigation fluids can all drive core temperature above the normal range, particularly in small patients or during short procedures with limited exposure.

Physiologic and Pathologic Hyperthermia

True fever, mediated by prostaglandin-induced elevation of the hypothalamic set point, can occur in anesthetized patients with underlying infection or inflammation. Malignant hyperthermia, a pharmacogenetic disorder of skeletal muscle calcium regulation, produces a dramatic rise in core temperature accompanied by muscle rigidity, tachycardia, and metabolic acidosis. Other causes include thyroid storm, pheochromocytoma, and heat stroke in patients with preexisting hyperthermia.

The physiologic response to severe hyperthermia includes progressive sympathetic activation. In a rat model of environmental heating, splanchnic sympathetic nerve activity and circulating catecholamine concentrations rose significantly as core temperature increased from 41 to 43°C, accompanied by hyperkalemia and lactacidemia. These findings, reported in Splanchnic sympathetic nerve activity and circulating catecholamines in the hyperthermic rat, illustrate the transition from compensatory thermoregulation to decompensated heat injury.

Monitoring Temperature in the Anesthetized Patient

Core Temperature Measurement Sites

Core temperature reflects the temperature of the central compartment, where the thermoregulatory center and vital organs reside. Peripheral sites lag behind core changes and may mislead clinical decisions. The pulmonary artery is the reference standard, but it is rarely practical in veterinary patients. The following sites offer clinically useful approximations of core temperature.

Place the probe before induction whenever possible to establish a baseline. Record temperature every 5 minutes during the procedure and every 15 minutes in recovery until the patient maintains normothermia without active support. The AAHA anesthesia and monitoring guidelines for dogs and cats recommend continuous temperature monitoring throughout the anesthetic period and into recovery.

Selecting a Warming Strategy

The choice of warming method depends on the patient's size, the anticipated duration of anesthesia, the surgical site, and the equipment available. No single device suits every situation.

Passive Insulation

Passive insulation includes blankets, bubble wrap, reflective foils, and surgical drapes. These materials reduce heat loss by trapping air and reflecting radiant heat, but they do not add energy to the patient. Passive insulation slows the rate of cooling by roughly 25% compared with no insulation. It is appropriate for short procedures under 30 minutes in patients at low risk of hypothermia, and it should be combined with active warming whenever the patient is hypothermic at induction or the procedure is expected to exceed 60 minutes.

Forced-Air Warming

Forced-air warming devices circulate warmed air through a disposable blanket placed over or under the patient. These systems deliver 200 to 800 W of heat depending on the model and temperature setting. They are the most effective clinically available warming method in small animal practice. Forced-air warming maintains normothermia in most dogs and cats during procedures lasting several hours. The blanket must be positioned to avoid covering the surgical field and to allow access to monitoring lines. Perforated blankets placed under the patient are less effective than over-blankets because the patient's weight compresses the air channels. Forced-air warming is less practical in large animals because commercial blankets do not fit adult horses or cattle, and the devices cannot overcome the large surface area and heat sink of a 500 kg patient.

Circulating-Water Blankets

Circulating-water blankets transfer heat through conductive contact. Modern multichannel blankets with channels that resist compression perform better than older single-channel designs. Water blankets are useful for large animal patients, where forced-air systems are impractical. They require a conductive interface, such as a thin towel or a purpose-built cover, to prevent contact burns. Set the water temperature at 38 to 42 degrees C for most patients. Higher settings increase burn risk, particularly in patients with poor peripheral perfusion, thin skin, or prolonged recumbency. Check the patient's skin every 30 minutes when using conductive warming.

Radiant Heaters

Radiant heaters warm the skin surface without direct contact. They are simple and inexpensive but inefficient, because much of the emitted energy misses the patient. Radiant heaters are useful in recovery cages for small patients and for neonatal or pediatric patients. They pose a burn risk if placed too close, and they do not warm the core effectively in larger patients. Radiant heaters should not be used as the sole warming method during a laparotomy or thoracotomy.

Heated Intravenous Fluids

Heated fluids prevent the heat loss associated with infusing cold crystalloids, but they do not warm the patient. A liter of fluid at room temperature requires roughly 17 kcal to reach body temperature, which is a trivial amount compared with the total heat deficit of a hypothermic patient. Fluid warming is most valuable during high-volume resuscitation or when large volumes of blood products are administered. Use a commercial fluid warmer instead of a microwave or a warm-water bath, because those methods cause hemolysis and inconsistent temperatures.

Heated Humidified Gases

Heating and humidifying inspired gases reduces respiratory heat loss, which accounts for roughly 10% of total anesthetic heat loss. The effect on core temperature is small in most patients, but it becomes relevant in small patients with high minute ventilation relative to body mass. Heated humidifiers add complexity to the breathing circuit and require careful monitoring to prevent airway burns or condensation obstructing the circuit.

Decision Framework for Hypothermia Management

Assess the patient's temperature at induction and again after 15 minutes of anesthesia. The rate of cooling is steepest in the first 30 to 60 minutes, so early intervention matters. Use the following framework to guide management.

In dogs and cats, the AAHA guidelines advise active warming for all patients anesthetized longer than 45 minutes and for all patients with an American Society of Anesthesiologists physical status of III or higher. For large animal practice, the MSD Veterinary Manual notes that hypothermia is less common in adult horses and cattle because of their size, but it becomes a significant risk in neonates, small ruminants, and any patient undergoing prolonged abdominal surgery.

Managing Hyperthermia Under Anesthesia

Hyperthermia during anesthesia is less common than hypothermia but carries greater immediate risk. The differential includes excessive active warming, high ambient temperature, pyrexia from the primary disease, malignant hyperthermia, and drug reactions. The approach differs depending on the cause.

Assessment Sequence

When the temperature rises above 39.2 degrees C in a dog or cat, or above the species-specific reference range in other species, follow this sequence.

First, verify the reading. Confirm the probe is in the correct position and that the monitor is functioning. A rectal probe that has slipped into feces or a nasopharyngeal probe that has been dislodged can produce false readings.

Second, assess the patient. Check heart rate, pulse quality, mucous membrane color, capillary refill time, and end-tidal carbon dioxide. Rising temperature with tachycardia, tachypnea, and rising end-tidal carbon dioxide suggests a hypermetabolic state. Rising temperature with normal or falling heart rate and stable end-tidal carbon dioxide suggests passive heat gain.

Third, review the environment. Check the warming device settings, the ambient room temperature, and the surgical lights. Turn off active warming devices and remove insulation. Increase the room ventilation or move the patient to a cooler area if possible.

Fourth, evaluate the drug history. Review the anesthetic record for drugs associated with hyperthermia, including anticholinergics, phenothiazines, and volatile anesthetics. Malignant hyperthermia is rare in dogs and cats but is well described in certain breeds, including Greyhounds, and in pigs. It presents with rapidly rising temperature, muscle rigidity, tachycardia, and a rising end-tidal carbon dioxide despite unchanged minute ventilation.

Fifth, treat the cause. For passive hyperthermia, removing the heat source and applying passive cooling is usually sufficient. For hypermetabolic states, active cooling is required. Apply cool water to the patient's extremities, place ice packs in the axillae and groin, and use a fan to increase evaporative heat loss. Stop cooling when the core temperature reaches 38.5 degrees C to avoid overshoot into hypothermia.

The WSAVA Global Pain Council Guidelines note that hyperthermia can also occur as a consequence of pain or distress in the recovery period. In that setting, treat the underlying pain instead of the temperature alone.

Documentation and Communication

Record the temperature at induction, every 5 minutes during anesthesia, and every 15 minutes in recovery. Document the warming devices used, their settings, and any changes made in response to temperature trends. Note the temperature at extubation and the time required to reach normothermia in recovery. This record supports clinical decisions during the current case and provides a baseline for future anesthetics in the same patient.

Communicate the temperature plan during the anesthetic handover. The recovery nurse or technician should know the target temperature range, the warming devices in use, and the threshold for escalating or de-escalating support. Hypothermia delays recovery from anesthesia, increases the duration of action of injectable anesthetics, and impairs coagulation and wound healing. The AVMA practice resources emphasize that perioperative temperature management is a component of standard anesthetic care and should be documented as such.

Recognized Complications and Failure Modes

Forced-air warmers are the most common cause of thermal injury during active warming. The risk rises when the warming blanket is placed directly against skin without a barrier, when the patient lies on the warming surface for prolonged periods, or when the unit is set to high and left unattended. Detection relies on scheduled skin checks at pressure points, particularly over the greater trochanter, sacrum, and elbows. Erythema that persists after blanching warrants repositioning and a reduction in warming intensity.

Circulating-water blankets carry a separate failure mode: channel kinking or pump malfunction can produce focal hot spots or complete loss of heating. The blanket should be inspected before use and the water temperature verified at the patient interface, not assumed from the pump display.

Overwarming of the head is a specific hazard in brachycephalic breeds and in patients positioned in dorsal recumbency. The brain is more vulnerable to hyperthermic injury than the body core, and temperature gradients between brain and body can widen during anesthesia. A warming device directed at the head should be avoided unless the patient is profoundly hypothermic, and even then the head should be monitored separately from the body.

Unrecognized probe displacement is the most dangerous monitoring failure. An esophageal probe that migrates into the pharynx reads lower than true core temperature, which can drive inappropriate warming. A rectal probe that becomes insulated by feces or loses mucosal contact reads variably. The discriminating check is to compare the displayed temperature against a second site and against the clinical context: a patient that is shivering, tachycardic, or peripherally vasoconstricted cannot be as warm as the probe suggests.

Common Errors and Corrective Actions

The most frequent error is treating the displayed temperature instead of the patient. A single reading from one site does not describe thermal status. Less experienced clinicians often escalate warming based on one low reading without first confirming probe position, checking the warming device, or assessing perfusion. The corrective action is a structured check: verify the probe, inspect the device, assess the patient, then intervene.

A second error is delaying active warming until hypothermia is established. The three-phase redistribution of heat begins within minutes of induction, and early intervention is far more effective than rescue warming. The decision to start active warming should be made during the anesthetic plan, not after the first temperature reading.

A third error is discontinuing warming at extubation. Core temperature continues to drift downward during recovery as vasodilation returns and the patient redistributes heat to the periphery. Warming should continue until the patient is normothermic and able to shiver effectively.

A fourth error is using a single warming modality for a large or heavily vasoconstricted patient. Forced-air warming alone may be insufficient in a 40 kg dog with poor peripheral perfusion. Combining a circulating-water blanket beneath the patient with forced air above provides more surface area and faster heat transfer.

Limitations of the Evidence and Areas of Disagreement

The evidence base for temperature management in veterinary anesthesia is drawn largely from experimental models and human medicine. The canine cerebral ischemia model demonstrates that temperature changes of 1 degree C or more alter neurologic outcome, but the direct applicability of these findings to routine clinical anesthesia is inferred instead of proven. Rodent studies show that body warming cannot fully compensate for anesthesia-induced brain hypothermia, yet the clinical significance of brain-body temperature gradients in dogs and cats remains uncertain.

Expert opinion differs on the target temperature for recovery. Some authorities advocate aggressive warming to a core temperature of 38 degrees C before extubation, while others accept 37 degrees C with continued warming during recovery. The AAHA guidelines emphasize continuous monitoring through recovery but do not specify a single discharge temperature. The MSD Veterinary Manual similarly describes general principles without endorsing a specific threshold.

The role of deliberate mild hypothermia as a protective strategy remains contested. Experimental evidence shows that hypothermia reduces metabolic demand and cardiac output, and some clinicians apply this principle to patients with cerebral injury. However, the risks of shivering, coagulopathy, and prolonged drug recovery generally outweigh the benefits in routine anesthesia, and the evidence does not support intentional hypothermia outside specific research or salvage contexts.

Escalation and Referral

Referral or specialist consultation is warranted when a patient cannot be rewarmed despite maximal active warming, when temperature exceeds 41 degrees C and does not respond to passive cooling, or when thermal injury is suspected. Persistent hypothermia despite adequate warming suggests an underlying problem: sepsis, severe hypothyroidism, or a failing warming device. Persistent hyperthermia despite cooling suggests malignant hyperthermia, sepsis, or a neurologic cause.

Laboratory involvement is indicated when hyperthermia is accompanied by unexplained acidosis, hyperkalemia, or rising creatine kinase. These findings raise the suspicion of malignant hyperthermia or another myopathy and warrant immediate diagnostic testing.

Regulatory reporting may be required when thermal injury results from equipment failure. The AVMA provides practice resources on adverse event reporting, and manufacturers should be notified of device malfunctions. In production animal settings, temperature management during anesthesia may intersect with welfare standards, and the WOAH terrestrial animal health standards describe expectations for animal care during procedures. Clinicians should be familiar with the reporting obligations in their jurisdiction.

Frequently Asked Questions

What Can I Do When Forced-Air Warming Is Not Available?

Conductive warming with a circulating water blanket is the most reliable alternative, provided it is placed correctly and the patient is positioned to maximize skin contact. Resistive heating pads and warmed intravenous fluids are useful adjuncts but are less effective alone. In small patients, covering the head and limbs with insulating material reduces radiant and convective losses. Increase the ambient room temperature to 26 to 28 degrees C, which is often the single most practical intervention in a resource-limited setting. Monitor core temperature frequently, because conductive devices can cause thermal injury if the patient lies still over a hot surface for prolonged periods. The AAHA anesthesia and monitoring guidelines recommend active warming for all patients under general anesthesia lasting longer than 45 minutes.

How Should I Manage Temperature in a Hypothermic Patient That Is Ready for Recovery?

Rewarming should begin before anesthetic delivery stops, because shivering in recovery increases oxygen consumption and metabolic demand substantially. Continue active warming until core temperature reaches at least 36.5 degrees C in dogs and cats, then transition to passive insulation. Remove warming devices gradually to avoid rebound hyperthermia, which can occur when vasoconstriction resolves and warm peripheral blood returns to the core. Provide supplemental oxygen and monitor heart rate and rhythm closely, as cold myocardium is more sensitive to arrhythmias. If the patient remains below 35 degrees C, delay extubation and continue active warming. The MSD Veterinary Manual emphasizes that recovery is a high-risk period for temperature-related complications and that normothermia should be confirmed before discharge from the hospital.

Does the Approach Differ for Rabbits, Birds, or Other Exotic Species?

Yes. Small mammals and birds have a higher surface area to volume ratio and lose heat faster than dogs and cats. They also have limited thermoregulatory reserve, so hypothermia can develop within minutes of anesthetic induction. Use prewarming before induction whenever possible, and maintain a higher ambient temperature, often 28 to 30 degrees C. Circulating water blankets are generally safe, but forced-air devices may be too aggressive for very small patients and carry a burn risk. Reptiles present the opposite problem: they are ectothermic and may require active warming to reach their preferred body temperature before anesthetic drugs are metabolized. Consult species-specific references, because normal temperature ranges vary widely and the WSAVA pain management guidelines note that analgesic and anesthetic choices interact with thermoregulatory capacity across species.

How Do I Document Temperature Management in the Anesthetic Record?

Record core temperature at induction, every 5 to 10 minutes during maintenance, and at least every 15 minutes in recovery until normothermia is confirmed. Note the monitoring site, because esophageal and rectal temperatures can differ by 0.5 degrees C or more. Document every warming intervention, including the device type, settings, and the time it was applied or removed. If the patient becomes hypothermic or hyperthermic, record the peak deviation, the corrective action taken, and the patient's response. This documentation supports clinical decision-making and provides a defensible record if complications arise. The AVMA practice resources advise that complete anesthetic records are a professional standard and should include physiologic parameters alongside drug and fluid administration.

What Should I Tell an Owner When Their Pet Is Hypothermic After Anesthesia?

Explain that hypothermia is a common and expected effect of general anesthesia, because anesthetic drugs suppress the brain's temperature-regulating center. Describe what you are doing to correct it, such as active warming and continued monitoring, and give a realistic timeline for recovery. Instruct the owner to keep the pet warm at home, but warn against using electric heating pads or hot water bottles, which can cause burns in a sedated animal. Advise them to monitor for shivering, lethargy, or cold extremities and to call the clinic if these persist beyond 24 hours. The AAHA anesthesia guidelines recommend providing written discharge instructions that include temperature-related observations.

When Should I Suspect Malignant Hyperthermia instead of Passive Hyperthermia?

Malignant hyperthermia is rare in dogs and cats but should be suspected when temperature rises rapidly, often more than 1 degree C in 10 to 15 minutes, in a patient receiving a volatile anesthetic, particularly halothane or sevoflurane. Concurrent signs include generalized muscle rigidity, tachycardia, tachypnea, and a rising end-tidal carbon dioxide despite unchanged ventilation. Passive hyperthermia develops more slowly and is usually associated with excessive warming, high ambient temperature, or inadequate heat dissipation. If malignant hyperthermia is suspected, discontinue the volatile agent, switch to total intravenous anesthesia, hyperventilate with 100 percent oxygen, and begin active cooling. Confirm the diagnosis with blood gas analysis showing metabolic acidosis and elevated creatine kinase. The MSD Veterinary Manual provides a detailed review of this syndrome and its distinguishing features.

Related Clinical & Scientific Guides

• Anesthetic Machine Leak Testing and Pressure Checks: A Step-by-Step Protocol
• Anesthetic Depth Assessment: Reflexes, Eye Position, and Ventilation
• Anesthesia for Patients with Obesity: Challenges and Solutions

References and Further Reading

• Temperature changes of > or = 1 degree C alter functional neurologic outcome and histopathology in a canine model of complete cerebral ischemia.. 1995.
• Brain and body temperature homeostasis during sodium pentobarbital anesthesia with and without body warming in rats.. 2005.
• Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice.. 2010.
• Effects of morphine, lidocaine, ketamine, and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane.. 2003.
• Effects of irrigation parameters and access sheath size on the intra-renal temperature during flexible ureteroscopy with a high-power laser.. 2021.
• Splanchnic sympathetic nerve activity and circulating catecholamines in the hyperthermic rat.. 1991.
• AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats. AAHA.
• WSAVA Global Pain Council Guidelines. WSAVA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Anesthesia for Patients with Skin Disease: Wound Management
• Electrocardiogram Monitoring in Anesthetized Veterinary Patients: Arrhythmia Recognition
• Anesthesia for Patients with Cancer: Paraneoplastic Syndromes
• Anesthesia for Patients with Sepsis: Hemodynamic Support
• Anesthesia for Patients with Trauma: Emergency Considerations

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.